Global Intravenous (IV) Solutions Market Size, Status and Forecast 2024-2031

Report ID: 1013122 | Published Date: Jan 2025 | No. of Page: 98 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Intravenous (IV) Solutions Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Peripheral Parenteral Nutrition
        1.2.3 Total Parenteral Nutrition
    1.3 Market by Application
        1.3.1 Global Intravenous (IV) Solutions Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital & Clinics
        1.3.3 Ambulatory
        1.3.4 Home Care
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Intravenous (IV) Solutions Market Perspective (2016-2027)
    2.2 Intravenous (IV) Solutions Growth Trends by Regions
        2.2.1 Intravenous (IV) Solutions Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Intravenous (IV) Solutions Historic Market Share by Regions (2016-2021)
        2.2.3 Intravenous (IV) Solutions Forecasted Market Size by Regions (2022-2027)
    2.3 Intravenous (IV) Solutions Industry Dynamic
        2.3.1 Intravenous (IV) Solutions Market Trends
        2.3.2 Intravenous (IV) Solutions Market Drivers
        2.3.3 Intravenous (IV) Solutions Market Challenges
        2.3.4 Intravenous (IV) Solutions Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Intravenous (IV) Solutions Players by Revenue
        3.1.1 Global Top Intravenous (IV) Solutions Players by Revenue (2016-2021)
        3.1.2 Global Intravenous (IV) Solutions Revenue Market Share by Players (2016-2021)
    3.2 Global Intravenous (IV) Solutions Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Intravenous (IV) Solutions Revenue
    3.4 Global Intravenous (IV) Solutions Market Concentration Ratio
        3.4.1 Global Intravenous (IV) Solutions Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Intravenous (IV) Solutions Revenue in 2020
    3.5 Intravenous (IV) Solutions Key Players Head office and Area Served
    3.6 Key Players Intravenous (IV) Solutions Product Solution and Service
    3.7 Date of Enter into Intravenous (IV) Solutions Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Intravenous (IV) Solutions Breakdown Data by Type
    4.1 Global Intravenous (IV) Solutions Historic Market Size by Type (2016-2021)
    4.2 Global Intravenous (IV) Solutions Forecasted Market Size by Type (2022-2027)

5 Intravenous (IV) Solutions Breakdown Data by Application
    5.1 Global Intravenous (IV) Solutions Historic Market Size by Application (2016-2021)
    5.2 Global Intravenous (IV) Solutions Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Intravenous (IV) Solutions Market Size (2016-2027)
    6.2 North America Intravenous (IV) Solutions Market Size by Type
        6.2.1 North America Intravenous (IV) Solutions Market Size by Type (2016-2021)
        6.2.2 North America Intravenous (IV) Solutions Market Size by Type (2022-2027)
        6.2.3 North America Intravenous (IV) Solutions Market Size by Type (2016-2027)
    6.3 North America Intravenous (IV) Solutions Market Size by Application
        6.3.1 North America Intravenous (IV) Solutions Market Size by Application (2016-2021)
        6.3.2 North America Intravenous (IV) Solutions Market Size by Application (2022-2027)
        6.3.3 North America Intravenous (IV) Solutions Market Size by Application (2016-2027)
    6.4 North America Intravenous (IV) Solutions Market Size by Country
        6.4.1 North America Intravenous (IV) Solutions Market Size by Country (2016-2021)
        6.4.2 North America Intravenous (IV) Solutions Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Intravenous (IV) Solutions Market Size (2016-2027)
    7.2 Europe Intravenous (IV) Solutions Market Size by Type
        7.2.1 Europe Intravenous (IV) Solutions Market Size by Type (2016-2021)
        7.2.2 Europe Intravenous (IV) Solutions Market Size by Type (2022-2027)
        7.2.3 Europe Intravenous (IV) Solutions Market Size by Type (2016-2027)
    7.3 Europe Intravenous (IV) Solutions Market Size by Application
        7.3.1 Europe Intravenous (IV) Solutions Market Size by Application (2016-2021)
        7.3.2 Europe Intravenous (IV) Solutions Market Size by Application (2022-2027)
        7.3.3 Europe Intravenous (IV) Solutions Market Size by Application (2016-2027)
    7.4 Europe Intravenous (IV) Solutions Market Size by Country
        7.4.1 Europe Intravenous (IV) Solutions Market Size by Country (2016-2021)
        7.4.2 Europe Intravenous (IV) Solutions Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Intravenous (IV) Solutions Market Size (2016-2027)
    8.2 Asia-Pacific Intravenous (IV) Solutions Market Size by Type
        8.2.1 Asia-Pacific Intravenous (IV) Solutions Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Intravenous (IV) Solutions Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Intravenous (IV) Solutions Market Size by Type (2016-2027)
    8.3 Asia-Pacific Intravenous (IV) Solutions Market Size by Application
        8.3.1 Asia-Pacific Intravenous (IV) Solutions Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Intravenous (IV) Solutions Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Intravenous (IV) Solutions Market Size by Application (2016-2027)
    8.4 Asia-Pacific Intravenous (IV) Solutions Market Size by Region
        8.4.1 Asia-Pacific Intravenous (IV) Solutions Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Intravenous (IV) Solutions Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Intravenous (IV) Solutions Market Size (2016-2027)
    9.2 Latin America Intravenous (IV) Solutions Market Size by Type
        9.2.1 Latin America Intravenous (IV) Solutions Market Size by Type (2016-2021)
        9.2.2 Latin America Intravenous (IV) Solutions Market Size by Type (2022-2027)
        9.2.3 Latin America Intravenous (IV) Solutions Market Size by Type (2016-2027)
    9.3 Latin America Intravenous (IV) Solutions Market Size by Application
        9.3.1 Latin America Intravenous (IV) Solutions Market Size by Application (2016-2021)
        9.3.2 Latin America Intravenous (IV) Solutions Market Size by Application (2022-2027)
        9.3.3 Latin America Intravenous (IV) Solutions Market Size by Application (2016-2027)
    9.4 Latin America Intravenous (IV) Solutions Market Size by Country
        9.4.1 Latin America Intravenous (IV) Solutions Market Size by Country (2016-2021)
        9.4.2 Latin America Intravenous (IV) Solutions Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Intravenous (IV) Solutions Market Size (2016-2027)
    10.2 Middle East & Africa Intravenous (IV) Solutions Market Size by Type
        10.2.1 Middle East & Africa Intravenous (IV) Solutions Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Intravenous (IV) Solutions Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Intravenous (IV) Solutions Market Size by Type (2016-2027)
    10.3 Middle East & Africa Intravenous (IV) Solutions Market Size by Application
        10.3.1 Middle East & Africa Intravenous (IV) Solutions Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Intravenous (IV) Solutions Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Intravenous (IV) Solutions Market Size by Application (2016-2027)
    10.4 Middle East & Africa Intravenous (IV) Solutions Market Size by Country
        10.4.1 Middle East & Africa Intravenous (IV) Solutions Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Intravenous (IV) Solutions Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 ICU Medical Inc. (U.S.)
        11.1.1 ICU Medical Inc. (U.S.) Company Details
        11.1.2 ICU Medical Inc. (U.S.) Business Overview
        11.1.3 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Introduction
        11.1.4 ICU Medical Inc. (U.S.) Revenue in Intravenous (IV) Solutions Business (2016-2021)
        11.1.5 ICU Medical Inc. (U.S.) Recent Development
    11.2 B. Braun Melsungen AG (Germany)
        11.2.1 B. Braun Melsungen AG (Germany) Company Details
        11.2.2 B. Braun Melsungen AG (Germany) Business Overview
        11.2.3 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Introduction
        11.2.4 B. Braun Melsungen AG (Germany) Revenue in Intravenous (IV) Solutions Business (2016-2021)
        11.2.5 B. Braun Melsungen AG (Germany) Recent Development
    11.3 Fresenius Kabi AG (Germany)
        11.3.1 Fresenius Kabi AG (Germany) Company Details
        11.3.2 Fresenius Kabi AG (Germany) Business Overview
        11.3.3 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Introduction
        11.3.4 Fresenius Kabi AG (Germany) Revenue in Intravenous (IV) Solutions Business (2016-2021)
        11.3.5 Fresenius Kabi AG (Germany) Recent Development
    11.4 Baxter (U.S.)
        11.4.1 Baxter (U.S.) Company Details
        11.4.2 Baxter (U.S.) Business Overview
        11.4.3 Baxter (U.S.) Intravenous (IV) Solutions Introduction
        11.4.4 Baxter (U.S.) Revenue in Intravenous (IV) Solutions Business (2016-2021)
        11.4.5 Baxter (U.S.) Recent Development
    11.5 Amanta Healthcare (India)
        11.5.1 Amanta Healthcare (India) Company Details
        11.5.2 Amanta Healthcare (India) Business Overview
        11.5.3 Amanta Healthcare (India) Intravenous (IV) Solutions Introduction
        11.5.4 Amanta Healthcare (India) Revenue in Intravenous (IV) Solutions Business (2016-2021)
        11.5.5 Amanta Healthcare (India) Recent Development
    11.6 Terumo Medical Corporation (Tokyo)
        11.6.1 Terumo Medical Corporation (Tokyo) Company Details
        11.6.2 Terumo Medical Corporation (Tokyo) Business Overview
        11.6.3 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Introduction
        11.6.4 Terumo Medical Corporation (Tokyo) Revenue in Intravenous (IV) Solutions Business (2016-2021)
        11.6.5 Terumo Medical Corporation (Tokyo) Recent Development
    11.7 Grifols S.A. (Spain)
        11.7.1 Grifols S.A. (Spain) Company Details
        11.7.2 Grifols S.A. (Spain) Business Overview
        11.7.3 Grifols S.A. (Spain) Intravenous (IV) Solutions Introduction
        11.7.4 Grifols S.A. (Spain) Revenue in Intravenous (IV) Solutions Business (2016-2021)
        11.7.5 Grifols S.A. (Spain) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Intravenous (IV) Solutions Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Peripheral Parenteral Nutrition
    Table 3. Key Players of Total Parenteral Nutrition
    Table 4. Global Intravenous (IV) Solutions Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Intravenous (IV) Solutions Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Intravenous (IV) Solutions Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Intravenous (IV) Solutions Market Share by Regions (2016-2021)
    Table 8. Global Intravenous (IV) Solutions Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Intravenous (IV) Solutions Market Share by Regions (2022-2027)
    Table 10. Intravenous (IV) Solutions Market Trends
    Table 11. Intravenous (IV) Solutions Market Drivers
    Table 12. Intravenous (IV) Solutions Market Challenges
    Table 13. Intravenous (IV) Solutions Market Restraints
    Table 14. Global Intravenous (IV) Solutions Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Intravenous (IV) Solutions Market Share by Players (2016-2021)
    Table 16. Global Top Intravenous (IV) Solutions Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous (IV) Solutions as of 2020)
    Table 17. Ranking of Global Top Intravenous (IV) Solutions Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Intravenous (IV) Solutions Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Intravenous (IV) Solutions Product Solution and Service
    Table 21. Date of Enter into Intravenous (IV) Solutions Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Intravenous (IV) Solutions Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Intravenous (IV) Solutions Revenue Market Share by Type (2016-2021)
    Table 25. Global Intravenous (IV) Solutions Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Intravenous (IV) Solutions Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Intravenous (IV) Solutions Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Intravenous (IV) Solutions Revenue Market Share by Application (2016-2021)
    Table 29. Global Intravenous (IV) Solutions Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Intravenous (IV) Solutions Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Intravenous (IV) Solutions Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Intravenous (IV) Solutions Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Intravenous (IV) Solutions Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Intravenous (IV) Solutions Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Intravenous (IV) Solutions Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Intravenous (IV) Solutions Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Intravenous (IV) Solutions Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Intravenous (IV) Solutions Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Intravenous (IV) Solutions Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Intravenous (IV) Solutions Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Intravenous (IV) Solutions Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Intravenous (IV) Solutions Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Intravenous (IV) Solutions Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Intravenous (IV) Solutions Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Intravenous (IV) Solutions Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Intravenous (IV) Solutions Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Intravenous (IV) Solutions Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Intravenous (IV) Solutions Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Intravenous (IV) Solutions Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Intravenous (IV) Solutions Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Intravenous (IV) Solutions Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Intravenous (IV) Solutions Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Intravenous (IV) Solutions Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Intravenous (IV) Solutions Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Intravenous (IV) Solutions Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Intravenous (IV) Solutions Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Intravenous (IV) Solutions Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Intravenous (IV) Solutions Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Intravenous (IV) Solutions Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Intravenous (IV) Solutions Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. ICU Medical Inc. (U.S.) Company Details
    Table 62. ICU Medical Inc. (U.S.) Business Overview
    Table 63. ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Product
    Table 64. ICU Medical Inc. (U.S.) Revenue in Intravenous (IV) Solutions Business (2016-2021) & (US$ Million)
    Table 65. ICU Medical Inc. (U.S.) Recent Development
    Table 66. B. Braun Melsungen AG (Germany) Company Details
    Table 67. B. Braun Melsungen AG (Germany) Business Overview
    Table 68. B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Product
    Table 69. B. Braun Melsungen AG (Germany) Revenue in Intravenous (IV) Solutions Business (2016-2021) & (US$ Million)
    Table 70. B. Braun Melsungen AG (Germany) Recent Development
    Table 71. Fresenius Kabi AG (Germany) Company Details
    Table 72. Fresenius Kabi AG (Germany) Business Overview
    Table 73. Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Product
    Table 74. Fresenius Kabi AG (Germany) Revenue in Intravenous (IV) Solutions Business (2016-2021) & (US$ Million)
    Table 75. Fresenius Kabi AG (Germany) Recent Development
    Table 76. Baxter (U.S.) Company Details
    Table 77. Baxter (U.S.) Business Overview
    Table 78. Baxter (U.S.) Intravenous (IV) Solutions Product
    Table 79. Baxter (U.S.) Revenue in Intravenous (IV) Solutions Business (2016-2021) & (US$ Million)
    Table 80. Baxter (U.S.) Recent Development
    Table 81. Amanta Healthcare (India) Company Details
    Table 82. Amanta Healthcare (India) Business Overview
    Table 83. Amanta Healthcare (India) Intravenous (IV) Solutions Product
    Table 84. Amanta Healthcare (India) Revenue in Intravenous (IV) Solutions Business (2016-2021) & (US$ Million)
    Table 85. Amanta Healthcare (India) Recent Development
    Table 86. Terumo Medical Corporation (Tokyo) Company Details
    Table 87. Terumo Medical Corporation (Tokyo) Business Overview
    Table 88. Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Product
    Table 89. Terumo Medical Corporation (Tokyo) Revenue in Intravenous (IV) Solutions Business (2016-2021) & (US$ Million)
    Table 90. Terumo Medical Corporation (Tokyo) Recent Development
    Table 91. Grifols S.A. (Spain) Company Details
    Table 92. Grifols S.A. (Spain) Business Overview
    Table 93. Grifols S.A. (Spain) Intravenous (IV) Solutions Product
    Table 94. Grifols S.A. (Spain) Revenue in Intravenous (IV) Solutions Business (2016-2021) & (US$ Million)
    Table 95. Grifols S.A. (Spain) Recent Development
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Intravenous (IV) Solutions Market Share by Type: 2020 VS 2027
    Figure 2. Peripheral Parenteral Nutrition Features
    Figure 3. Total Parenteral Nutrition Features
    Figure 4. Global Intravenous (IV) Solutions Market Share by Application: 2020 VS 2027
    Figure 5. Hospital & Clinics Case Studies
    Figure 6. Ambulatory Case Studies
    Figure 7. Home Care Case Studies
    Figure 8. Intravenous (IV) Solutions Report Years Considered
    Figure 9. Global Intravenous (IV) Solutions Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Intravenous (IV) Solutions Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Intravenous (IV) Solutions Market Share by Regions: 2020 VS 2027
    Figure 12. Global Intravenous (IV) Solutions Market Share by Regions (2022-2027)
    Figure 13. Global Intravenous (IV) Solutions Market Share by Players in 2020
    Figure 14. Global Top Intravenous (IV) Solutions Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous (IV) Solutions as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Intravenous (IV) Solutions Revenue in 2020
    Figure 16. Global Intravenous (IV) Solutions Revenue Market Share by Type (2016-2021)
    Figure 17. Global Intravenous (IV) Solutions Revenue Market Share by Type (2022-2027)
    Figure 18. North America Intravenous (IV) Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Intravenous (IV) Solutions Market Share by Type (2016-2027)
    Figure 20. North America Intravenous (IV) Solutions Market Share by Application (2016-2027)
    Figure 21. North America Intravenous (IV) Solutions Market Share by Country (2016-2027)
    Figure 22. United States Intravenous (IV) Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Intravenous (IV) Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Intravenous (IV) Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Intravenous (IV) Solutions Market Share by Type (2016-2027)
    Figure 26. Europe Intravenous (IV) Solutions Market Share by Application (2016-2027)
    Figure 27. Europe Intravenous (IV) Solutions Market Share by Country (2016-2027)
    Figure 28. Germany Intravenous (IV) Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Intravenous (IV) Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Intravenous (IV) Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Intravenous (IV) Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Intravenous (IV) Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Intravenous (IV) Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Intravenous (IV) Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Intravenous (IV) Solutions Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Intravenous (IV) Solutions Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Intravenous (IV) Solutions Market Share by Region (2016-2027)
    Figure 38. China Intravenous (IV) Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Intravenous (IV) Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Intravenous (IV) Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Intravenous (IV) Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Intravenous (IV) Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Intravenous (IV) Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Intravenous (IV) Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Intravenous (IV) Solutions Market Share by Type (2016-2027)
    Figure 46. Latin America Intravenous (IV) Solutions Market Share by Application (2016-2027)
    Figure 47. Latin America Intravenous (IV) Solutions Market Share by Country (2016-2027)
    Figure 48. Mexico Intravenous (IV) Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Intravenous (IV) Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Intravenous (IV) Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Intravenous (IV) Solutions Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Intravenous (IV) Solutions Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Intravenous (IV) Solutions Market Share by Country (2016-2027)
    Figure 54. Turkey Intravenous (IV) Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Intravenous (IV) Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Intravenous (IV) Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. ICU Medical Inc. (U.S.) Revenue Growth Rate in Intravenous (IV) Solutions Business (2016-2021)
    Figure 58. B. Braun Melsungen AG (Germany) Revenue Growth Rate in Intravenous (IV) Solutions Business (2016-2021)
    Figure 59. Fresenius Kabi AG (Germany) Revenue Growth Rate in Intravenous (IV) Solutions Business (2016-2021)
    Figure 60. Baxter (U.S.) Revenue Growth Rate in Intravenous (IV) Solutions Business (2016-2021)
    Figure 61. Amanta Healthcare (India) Revenue Growth Rate in Intravenous (IV) Solutions Business (2016-2021)
    Figure 62. Terumo Medical Corporation (Tokyo) Revenue Growth Rate in Intravenous (IV) Solutions Business (2016-2021)
    Figure 63. Grifols S.A. (Spain) Revenue Growth Rate in Intravenous (IV) Solutions Business (2016-2021)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
ICU Medical Inc. (U.S.)
B. Braun Melsungen AG (Germany)
Fresenius Kabi AG (Germany)
Baxter (U.S.)
Amanta Healthcare (India)
Terumo Medical Corporation (Tokyo)
Grifols S.A. (Spain)
Frequently Asked Questions
Intravenous (IV) Solutions report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Intravenous (IV) Solutions report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Intravenous (IV) Solutions report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports